Research has found that, when reintroduced into the body, polylaminin can help the longest part of the neuron open a new path at the site of the injury to the next neuron, generating the electrical impulse necessary to perform a movement.
On Tuesday (9), Brazilian scientists presented the results of research they have been conducting for over 25 years. In the experimental phase, treatment based on a protein extracted from the placenta restored some movement in dogs and humans who had spinal cord injuries. Anvisa still needs to authorize new clinical trials to ensure patient safety.
https://ensaiosclinicos.gov.br/news/331